drugset / Trial / NCT03733379

Systemic Probiotics in the Periodontal Treatment

NCT03733379

Phase 3 Unknown 176 enrolled Belén Retamal-Valdes
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this multicenter randomized clinical trial is to evaluate the clinical, microbiological and immunological effects of probiotics as an adjunct to Scaling and Root Planing alone or in combination with Metronidazole and Amoxicillin in the treatment of periodontitis.

Timeline

Start
2018-11-05
Primary completion
2020-12-30
Completion
2021-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 500 mg
Subject Metronidazole Small molecule

Indications